(E)-3-(4-(2-(二甲氨基)乙氧基)-3-甲氧苯基)丙烯酸对大鼠局灶性脑缺血的保护作用及机制

中国临床药理学与治疗学 ›› 2010, Vol. 15 ›› Issue (5): 502-506.

(E)-3-(4-(2-(二甲氨基)乙氧基)-3-甲氧苯基)丙烯酸对大鼠局灶性脑缺血的保护作用及机制

吉蕊, 陈莉, 吴玉林

中国药科大学生理教研室,南京 210009,江苏

收稿日期:2010-03-11 修回日期:2010-04-10 出版日期:2010-05-26 发布日期:2020-09-16
通讯作者: 吴玉林,男,博士,副教授,硕士生导师,从事心血管药理研究。E-mail: wylcpu@yahoo.com.cn
作者简介:吉蕊,女,硕士,从事心血管药理研究。Tel: 13611513181 E-mail: mavisji121935@163.com

Protective effects and the mechanisms of DEAAA on focal cerebral ischemia in rats

JI Rui, CHEN Li, WU Yu-lin

Department of Physiology, China Pharmaceutical University, Nanjing 210009, Jiangsu, China

Received:2010-03-11 Revised:2010-04-10 Online:2010-05-26 Published:2020-09-16

摘要/Abstract

摘要： 目的: 研究(E)-3-(4-(2-(二甲氨基)乙氧基)-3-甲氧苯基)丙烯酸(DEAAA)对大鼠局灶性脑缺血的保护作用及作用机制。方法: 建立大鼠大脑中动脉阻塞模型(MCAO),以奥扎格雷为阳性对照组,观察DEAAA各剂量组(30、18、10.8 mg/kg)对脑缺血大鼠神经行为、脑含水量、脑梗死面积、脑组织生化指标和脑组织病理变化的影响。结果: DEAAA(30、18 mg/kg)可显著降低脑水肿程度,减少脑梗死面积(P<0.05 和P<0.01 vs缺血模型组),并增加MCAO大鼠脑组织超氧化物歧化酶含量、升高乳酸脱氢酶活力并且降低丙二醛水平(P<0.05 和P<0.01 vs缺血模型组),明显改善大鼠神经行为(P<0.05 和P<0.01 vs缺血模型组),改善脑组织神经细胞缺血后的病理改变。结论: DEAAA对脑缺血大鼠有保护作用,其机制可能与抗氧化、提高自由基清除能力、增强脑组织抵抗缺氧能力有关。

关键词: 奥扎格雷, 局灶性脑缺血, 保护作用, 缺氧

Abstract: AIM: To study the protective effects of (E)-3-(4-(2-(dimethylamino) ethoxyl)-3-anisyl) acrylic acid(DEAAA) on focal cerebral ischemia of rats. METHODS: Middle cerebral artery occlusion(MCAO) model was used to evaluate the drug's effects. With Ozagrel as a positive control drug, after cerebral ischemia, the effect of different doses of DEAAA on the neurological behaviors, the cerebral water volumes, the cerebral infarction areas, the cerebral biochemistry and the pathologic change of brains were evaluated. RESULTS: DEAAA (30, 18 mg/kg) decreased the cerebral water volumes and the cerebral infarction areas(P<0.05, P<0.01), increased the levels of SOD and LDH, decreased the content of MDA in brain(P<0.05, P<0.01), improved neurological behaviors of the MCAO rats(P<0.05, P<0.01) and improved the pathologic change of brain after cerebral ischemia. CONCLUSION: DEAAA has the protective effects on cerebral ischemia in rats, the mechanisms of DEAAA involved in anti-oxidation, improving energy metabolism and increasing the ability of getting rid of free radicals.

Key words: Ozagrel, Focal cerebral ischemia, Protective effects, Anoxia

中图分类号:

R965.2

吉蕊, 陈莉, 吴玉林. (E)-3-(4-(2-(二甲氨基)乙氧基)-3-甲氧苯基)丙烯酸对大鼠局灶性脑缺血的保护作用及机制[J]. 中国临床药理学与治疗学, 2010, 15(5): 502-506.

JI Rui, CHEN Li, WU Yu-lin. Protective effects and the mechanisms of DEAAA on focal cerebral ischemia in rats[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(5): 502-506.

参考文献

[1] 唐康, 张均田. 脑缺血损伤机制和治疗策略研究进展[J]. 中国新药杂志, 2000,9(12): 809-813.
[2] 沈磊, 张鸽, 吴玉林. 淫羊藿总黄铜对大鼠局灶性脑缺血的保护作用[J]. 中药新药与临床药理, 2007,18(4):266-269.
[3] Matsuo Y, Kihara T, Ikeda M, et al. Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain[J]. Brain Res, 1996,709(2):296-302.
[4] 钱秀琴. 奥扎格雷治疗急性脑梗死疗效分析[J]. 中国医药指南, 2009,4(7):80-82.
[5] 任玉峰. 奥扎格雷钠对大鼠局灶性脑缺血再灌注损伤保护作用的研究[D]. 大连医科大学, 2006.
[6] 颜琳琦, 金瓯, 郭兴杰. 奥扎格雷在大鼠体内的药代动力学研究[J]. 药物研究, 2009,18(9):12-14.
[7] 徐叔云, 卞如濂, 陈修. 药理实验方法学[M]. 3版. 北京: 人民卫生出版社, 2002:1066-1067.
[8] Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989,20(1):84-91.
[9] Huang G, Cao X, Zhang X, et al. Effect of soybean isoflavone on the notch signal pathway of the brain in rats with cerebral ischemia[J]. J Nutr Sci Vitaminol, 2009,55(4):326-331.
[10] Liang S, Pong K, Gonzales C, et al. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia[J]. J PET, 2009,331(3):827-835.
[11] Iadecola C, Zhang F, Casey R, et al. Inducible nitric oxide synthase gene expression in vascular cells after tran-sient focal cerebral ischemia[J]. Stroke, 1996,27(8):1373-1380.
[12] 来滨, 李双成, 张卫国. 脑缺血时神经细胞死亡机制的研究进展[J]. 河北医科大学学报, 2002,23(1):44-46.
[13] Phillis JW. Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex[J]. Brain Res, 1998,780(2):35.
[14] Pu F, Motohashi K, Kaneko T, et al. Neuroprotective effects of Kangen-karyu on spatial memory impairment in an 8-arm radial maze and neuronal death in the hippocampal CA1 region induced by repeated cerebral ischemia in rats[J]. J Pharmacol Sci, 2009,109(3):424-430.
[15] 王姗, 李家明, 何广卫,等. MC-001对大鼠脑缺血-再灌注损伤的保护作用及机制[J]. 中国临床药理学与治疗学, 2008,13(11):1254-1258.
[16] 海舰, 丁美修. 脑缺血再灌注时血脑屏障损伤的炎性机制[J]. 国外医学脑血管疾病分册, 2001,9(1):15-18.
[17] Kagiyama T, Glushakov AV, Sumners C, et al. Neuroprotective action of halogenated derivatives of L-phenylalanine[J]. Stroke, 2004,35(5):1192-1196.
[18] Pedersen JZ, Bernardi G, Centonze D, et al. Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation[J]. J Cereb Blood Flow Metab, 1998,18(8):868-875.
[19] 郭胜蓝, 孙莉莎, 欧阳石,等. 虎杖苷对大鼠急性脑缺血再灌注损伤的保护作用[J]. 时珍国医国药, 2005,16(5):414-416.
[20] Chang Y, Hsieh CY, Peng ZA, et al. Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats[J]. J Biomed Sci, 2009,16:9-22.
[17] McCord JM. Oxygen-Derived free radicals in post ischemic tissue injury[J]. N Engl J Med, 1985,312:159.
[21] Lmazumi S, Tominage T, Uenohara H, et al. Intiation and propagation of lipid per oxidation in cerebral infarction models[J]. Neurol Res, 1986,8:214.
[22] 徐仁四, 孙圣刚, 梅元武. 线粒体钙、钙调素、兴奋性氨基酸、丙二醛在脑缺血再灌注中变化的实验观察[J]. 脑与神经疾病杂志, 1999,7(5):261-263.
[23] 王绍斌, 李卫平, 何婷,等. 黄芪提取物对全脑缺血损伤的保护作用[J]. 中国药理学通报, 2004,20(3):338-342.